4//SEC Filing
BITAR PATRICIA L 4
Accession 0001209191-21-070776
CIK 0001785345other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:22 PM ET
Size
6.1 KB
Accession
0001209191-21-070776
Insider Transaction Report
Form 4
BITAR PATRICIA L
Interim CFO
Transactions
- Award
Stock Option (right to buy)
2021-12-17+87,513→ 87,513 totalExercise: $4.95Exp: 2031-12-16→ Common Stock (87,513 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in six equal monthly installments from the vesting commencement date, subject to the Reporting Person's continuous service with the issuer at each vesting date. If the Reporting Person's employment is terminated prior to February 15, 2022 in connection with the employment of a regular Chief Financial Officer approved by the issuer's board of directors, then 58,341 of the unvested shares underlying the option will become fully vested on the termination date and the remaining shares will be forfeited. If the Reporting Person's employment is terminated on or after February 15, 2022 in connection with the employment of a regular Chief Financial Officer approved by the issuer's board of directors, then all unvested shares underlying the option will become fully vested on the termination date.
Documents
Issuer
Landos Biopharma, Inc.
CIK 0001785345
Entity typeother
Related Parties
1- filerCIK 0001631349
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:22 PM ET
- Size
- 6.1 KB